Emerging research and real-world experience suggest GLP-1 meds help reduce flares, pain, and inflammation in various inflammatory and autoimmune diseases, especially when obesity or insulin resistance is also present. What are the current barriers to getting GLP-1 medications (cost, coverage)
The in vitro research effects of this carrier peptides is to deliver copper to the skin to activate enzymatic wound-healing pathways, while the desired, in vivo, effect is to make the skin more smooth, thick, and firm due to increased collagen production
Hormonal variables are relevant to BPC-157 outcomes in women primarily in the context of perimenopause and menopause, where declining estrogen affects collagen synthesis rates and tissue healing capacity
The SURMOUNT-OSA and SCALE clinical trials found that GLP-RAs (tirzepatide and liraglutide, respectively) significantly lowered OSA severity and body weight in adults with comorbid OSA and obesity (Malhotra et al., 2024